☰

Cedric Mombereau - Publications

Affiliations: 
University of Pennsylvania, Philadelphia, PA, United States 
Area:
Depression, addiction, behavior
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Rotolo RA, Ecevitoglu A, Presby RE, Lindgren H, Mombereau C, Nicholas C, Moore A, Edelstein GA, Correa M, Salamone JD. Effort-related effects of chronic administration of the DA D receptor antagonist haloperidol via subcutaneous programmable minipumps: Reversal by co-administration of the adenosine A2A antagonist istradefylline. Psychopharmacology. PMID 37615683 DOI: 10.1007/s00213-023-06439-y  0.308
2017 Mombereau C, Arnt J, Mørk A. Involvement of presynaptic 5-HT1A receptors in the low propensity of brexpiprazole to induce extrapyramidal side effects in rats. Pharmacology, Biochemistry, and Behavior. 153: 141-146. PMID 28057524 DOI: 10.1016/j.pbb.2016.12.015  0.306
2010 Mombereau C, Kawahara Y, Gundersen BB, Nishikura K, Blendy JA. Functional relevance of serotonin 2C receptor mRNA editing in antidepressant- and anxiety-like behaviors. Neuropharmacology. 59: 468-73. PMID 20624407 DOI: 10.1016/j.neuropharm.2010.06.009  0.692
2010 Mombereau C, Gur TL, Onksen J, Blendy JA. Differential effects of acute and repeated citalopram in mouse models of anxiety and depression. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 321-34. PMID 20003619 DOI: 10.1017/S1461145709990630  0.618
2008 Kawahara Y, Grimberg A, Teegarden S, Mombereau C, Liu S, Bale TL, Blendy JA, Nishikura K. Dysregulated editing of serotonin 2C receptor mRNAs results in energy dissipation and loss of fat mass. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 12834-44. PMID 19036977 DOI: 10.1523/Jneurosci.3896-08.2008  0.586
2007 Mombereau C, Lhuillier L, Kaupmann K, Cryan JF. GABAB receptor-positive modulation-induced blockade of the rewarding properties of nicotine is associated with a reduction in nucleus accumbens DeltaFosB accumulation. The Journal of Pharmacology and Experimental Therapeutics. 321: 172-7. PMID 17215447 DOI: 10.1124/jpet.106.116228  0.724
2007 Lhuillier L, Mombereau C, Cryan JF, Kaupmann K. GABA(B) receptor-positive modulation decreases selective molecular and behavioral effects of cocaine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 388-98. PMID 16710312 DOI: 10.1038/sj.npp.1301102  0.728
2006 Mitsukawa K, Mombereau C, Lötscher E, Uzunov DP, van der Putten H, Flor PJ, Cryan JF. Metabotropic glutamate receptor subtype 7 ablation causes dysregulation of the HPA axis and increases hippocampal BDNF protein levels: implications for stress-related psychiatric disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 1112-22. PMID 16237391 DOI: 10.1038/sj.npp.1300926  0.547
2006 Lhuillier L, Mombereau C, Cryan J, Kaupmann K. GABAB receptor positive modulation attenuates selected molecular markers relevant to cocaine and nicotine dependence European Neuropsychopharmacology. 16: S11-S12. DOI: 10.1016/S0924-977X(06)80015-5  0.557
2005 Mitsukawa K, Yamamoto R, Ofner S, Nozulak J, Pescott O, Lukic S, Stoehr N, Mombereau C, Kuhn R, McAllister KH, van der Putten H, Cryan JF, Flor PJ. A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo. Proceedings of the National Academy of Sciences of the United States of America. 102: 18712-7. PMID 16339898 DOI: 10.1073/pnas.0508063102  0.527
2005 Cryan JF, Mombereau C, Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neuroscience and Biobehavioral Reviews. 29: 571-625. PMID 15890404 DOI: 10.1016/j.neubiorev.2005.03.009  0.487
2005 Mombereau C, Kaupmann K, Gassmann M, Bettler B, van der Putten H, Cryan JF. Altered anxiety and depression-related behaviour in mice lacking GABAB(2) receptor subunits. Neuroreport. 16: 307-10. PMID 15706241 DOI: 10.1097/00001756-200502280-00021  0.578
2005 Slattery D, Mombereau C, Froestl W, Markou A, Kaupmann K, Cryan J. P.2.19 GABAB receptor positive modulation as a novel therapeutic approach to drug dependence: blockade of the rewarding and psychostimulant effects of cocaine European Neuropsychopharmacology. 15: S45-S46. DOI: 10.1016/S0924-977X(05)80159-2  0.701
2004 Mombereau C, Kaupmann K, van der Putten H, Cryan JF. Altered response to benzodiazepine anxiolytics in mice lacking GABA B(1) receptors. European Journal of Pharmacology. 497: 119-20. PMID 15321743 DOI: 10.1016/j.ejphar.2004.06.036  0.531
2004 Gassmann M, Shaban H, Vigot R, Sansig G, Haller C, Barbieri S, Humeau Y, Schuler V, Müller M, Kinzel B, Klebs K, Schmutz M, Froestl W, Heid J, Kelly PH, ... ... Mombereau C, et al. Redistribution of GABAB(1) protein and atypical GABAB responses in GABAB(2)-deficient mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 6086-97. PMID 15240800 DOI: 10.1523/Jneurosci.5635-03.2004  0.552
2004 Cryan JF, Kelly PH, Chaperon F, Gentsch C, Mombereau C, Lingenhoehl K, Froestl W, Bettler B, Kaupmann K, Spooren WP. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines. The Journal of Pharmacology and Experimental Therapeutics. 310: 952-63. PMID 15113848 DOI: 10.1124/Jpet.104.066753  0.599
2004 Mombereau C, Kaupmann K, Froestl W, Sansig G, van der Putten H, Cryan JF. Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1050-62. PMID 15039762 DOI: 10.1038/sj.npp.1300413  0.529
2004 Spooren W, Mombereau C, Maco M, Gill R, Kemp JA, Ozmen L, Nakanishi S, Higgins GA. Pharmacological and genetic evidence indicates that combined inhibition of NR2A and NR2B subunit containing NMDA receptors is required to disrupt prepulse inhibition. Psychopharmacology. 175: 99-105. PMID 14985927 DOI: 10.1007/s00213-004-1785-y  0.322
2004 Cryan JF, Mombereau C. In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Molecular Psychiatry. 9: 326-57. PMID 14743184 DOI: 10.1038/sj.mp.4001457  0.5
2004 Mombereau C, Kaupmann K, Froestl W, van der Putten H, Cryan J. S.07.03 GABAB receptors play a key rolein the modulation of anxiety and antidepressant-related behaviour: Genetic and pharmacological evidence European Neuropsychopharmacology. 14: S125. DOI: 10.1016/S0924-977X(04)80024-5  0.538
2003 Kaupmann K, Cryan JF, Wellendorph P, Mombereau C, Sansig G, Klebs K, Schmutz M, Froestl W, van der Putten H, Mosbacher J, Bräuner-Osborne H, Waldmeier P, Bettler B. Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice. The European Journal of Neuroscience. 18: 2722-30. PMID 14656321 DOI: 10.1111/J.1460-9568.2003.03013.X  0.541
Show low-probability matches.